Effect of Vaginal Estrogen on Asymptomatic Microhematuria (AMH): A Randomized Controlled Trial [EVER Study]

Trial Profile

Effect of Vaginal Estrogen on Asymptomatic Microhematuria (AMH): A Randomized Controlled Trial [EVER Study]

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 23 Sep 2016

At a glance

  • Drugs Conjugated estrogens (Primary)
  • Indications Haematuria
  • Focus Therapeutic Use
  • Acronyms EVER study
  • Most Recent Events

    • 15 Mar 2016 Planned End Date changed from 1 Oct 2015 to 1 Dec 2017 as per ClinicalTrials.gov record.
    • 15 Mar 2016 Planned primary completion date changed from 1 Sep 2015 to 1 Sep 2017 as per ClinicalTrials.gov record.
    • 13 Aug 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top